Crane Harbor Acquisition II (CRAN) vs Drugs Made In America Acquisition II (DMII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $473.7 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CRAN | DMII |
|---|---|---|
| Share price | $10.10 | $10.19 |
| Market cap | $473.69M | $649.10M |
| 1-day change | 0.00% | 0.00% |
| P/E ratio (TTM) | — | 33.97 |
| EPS (TTM) | — | $0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.21 | $10.33 |
| 52-week low | $9.13 | $9.86 |
| Distance from 52-week high | -1.08% | -1.36% |
| Average volume | 48.53K | 57.23K |
| Shares outstanding | 35.40M | 63.70M |
| Sector | Finance | Finance |
| Industry | Blank Checks | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Crane Harbor Acquisition II
CRAN stock →Crane Harbor Acquisition Corp. II does not have significant operations.
Finance · Blank Checks
About Drugs Made In America Acquisition II
DMII stock →Drugs Made In America Acquisition II Corp. does not have significant operations.
Finance · Blank Checks
CRAN vs DMII FAQ
Which is bigger, Crane Harbor Acquisition II or Drugs Made In America Acquisition II?
Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $473.69M for Crane Harbor Acquisition II (CRAN).
Are Crane Harbor Acquisition II and Drugs Made In America Acquisition II in the same industry?
Yes. Both are classified in the Blank Checks industry within the Finance sector.